← Leaderboards
Steven C. Almo
Yeshiva University
$55,216,276
Attributed
$64,062,042
Total exposure
30
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$96,828,681 · 32
By mechanism
U54$58,924,396 · 5
R01$23,522,662 · 11
P01$6,160,803 · 3
U09$4,930,900 · 1
P30$1,758,971 · 6
S10$600,000 · 1
Top collaborators
- Harris Goldstein12 shared
- Teresa P Dilorenzo10 shared
- Dorit Hanein4 shared
- Niels Volkmann4 shared
- Tyler L Grove3 shared
- Edward Chu1 shared
- Betsy C. Herold1 shared
Most similar at Yeshiva University
Same institution · by research overlap
- Sunhee C Lee$6,609,780
- Pamela M Stanley$27,087,260
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionBaseStructureBiologicalProteinsDesignCellsStructural BiologyLigandsProgramsTechnologyPeptidesMalignant NeoplasmsNovel StrategiesLinkIn VivoReceptorGenerationsMemberData CollectionNew YorkLaboratoriesInsightCrystallization
Grant awards (118)
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$1,679,994
R01 · FY2025 · AI
The Unexpected Role of TNFRSF14 Signaling in Promoting Antibody-Dependent Cell-Mediated Cytotoxicity$493,920
R01 · FY2025 · AI
Structural Biology Shared Resource$116,191
P30 · FY2025 · CA · contact PI
Cancer Therapeutics Program$57,915
P30 · FY2025 · CA · contact PI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$839,997
R01 · FY2024 · AI
Structural Biology Shared Resource$107,355
P30 · FY2024 · CA · contact PI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$99,295
R01 · FY2024 · AI
Cancer Therapeutics Program$53,509
P30 · FY2024 · CA · contact PI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$839,997
R01 · FY2023 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission$829,213
R01 · FY2023 · AI
Structural Biology Shared Resource$112,532
P30 · FY2023 · CA · contact PI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$99,295
R01 · FY2023 · AI
Cancer Therapeutics Program$56,090
P30 · FY2023 · CA · contact PI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$19,349
R01 · FY2023 · AI
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection$839,997
R01 · FY2022 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission$829,213
R01 · FY2022 · AI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2022 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission$829,213
R01 · FY2021 · AI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2021 · AI
Structural Biology$140,859
P30 · FY2021 · CA · contact PI
Cancer Therapuetics$32,730
P30 · FY2021 · CA · contact PI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission$829,213
R01 · FY2020 · AI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$715,797
R01 · FY2020 · AI
Protein/Structure Core$631,748
P01 · FY2020 · GM · contact PI
Novel Strategies for Precision T-cell Therapies$520,564
R01 · FY2020 · CA · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$501,000
R01 · FY2020 · DK
Ligand Discovery Project$428,489
P01 · FY2020 · GM · contact PI
Novel Biologics to Treat Lung Cancer and COVID-19 Comorbidity$167,791
P30 · FY2020 · CA
Structural Biology$139,665
P30 · FY2020 · CA · contact PI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission$829,213
R01 · FY2019 · AI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$716,287
R01 · FY2019 · AI
Protein/Structure Core$631,748
P01 · FY2019 · GM · contact PI
Structural basis of allostery and mechanical properties of F-actin$563,111
R01 · FY2019 · GM
Novel Strategies for Precision T-cell Therapies$504,946
R01 · FY2019 · CA · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$501,000
R01 · FY2019 · DK
Ligand Discovery Project$428,489
P01 · FY2019 · GM · contact PI
Structural Biology$139,665
P30 · FY2019 · CA · contact PI
Novel Strategies for Precision T-cell Therapies$116,287
R01 · FY2019 · CA · contact PI
Protein/Structure Core$631,748
P01 · FY2018 · GM · contact PI
Structural basis of allostery and mechanical properties of F-actin$564,263
R01 · FY2018 · GM
Ligand Discovery Project$428,489
P01 · FY2018 · GM · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$415,917
R01 · FY2018 · DK
Novel Strategies for Precision T-cell Therapies$411,577
R01 · FY2018 · CA · contact PI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$367,866
R01 · FY2018 · AI
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells$364,190
R01 · FY2018 · AI
Novel Strategies for Precision T-cell Therapies$159,311
R01 · FY2018 · CA · contact PI
Function and Mechanism of Viperin, a radical SAM antiviral protein$121,679
R21 · FY2018 · AI · contact PI
Function and Mechanism of Viperin, a radical SAM antiviral protein$87,071
R21 · FY2018 · AI · contact PI
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes$85,083
R01 · FY2018 · DK
Novel Strategies for Precision T-cell Therapies$57,107
R01 · FY2018 · CA · contact PI
Protein/Structure Core$568,574
P01 · FY2017 · GM · contact PI
Structural basis of allostery and mechanical properties of F-actin$565,384
R01 · FY2017 · GM
Novel Strategies for Precision T-cell Therapies$520,564
R01 · FY2017 · CA · contact PI
Technologies for Mapping the Extracellular Interactome$496,707
R01 · FY2017 · HG · contact PI
Ligand Discovery Project$385,640
P01 · FY2017 · GM · contact PI
Function and Mechanism of Viperin, a radical SAM antiviral protein$250,500
R21 · FY2017 · AI · contact PI
Technologies for Mapping the Extracellular Interactome$151,293
R01 · FY2017 · HG · contact PI
Technologies for Mapping the Extracellular Interactome$648,000
R01 · FY2016 · HG · contact PI
Structural basis of allostery and mechanical properties of F-actin$613,971
R01 · FY2016 · GM
Protein/Structure Core$531,298
P01 · FY2016 · GM · contact PI
Novel Strategies for Precision T-cell Therapies$520,564
R01 · FY2016 · CA · contact PI
Ligand Discovery Project$363,397
P01 · FY2016 · GM · contact PI
Core E: Protein$762,924
U54 · FY2015 · GM · contact PI
Technologies for Mapping the Extracellular Interactome$648,000
R01 · FY2015 · HG · contact PI
Core F: Structure$399,599
U54 · FY2015 · GM · contact PI
An integrated X-ray data collection system$300,000
S10 · FY2015 · OD · contact PI
An integrated X-ray data collection system$300,000
S10 · FY2015 · OD · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$5,792,798
U54 · FY2014 · GM · contact PI
Project 1$2,674,840
U54 · FY2014 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$403,158
U54 · FY2014 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$6,403,511
U54 · FY2013 · GM · contact PI
Project 1$2,960,989
U54 · FY2013 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$250,500
U54 · FY2013 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$6,634,519
U54 · FY2012 · GM · contact PI
Project 1$3,071,128
U54 · FY2012 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$175,680
U54 · FY2012 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$5,855,992
U54 · FY2011 · GM · contact PI
Project 1$3,169,922
U54 · FY2011 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$597,600
U54 · FY2011 · GM · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$360,000
U54 · FY2011 · GM · contact PI
STRUCTURAL BIOLOGY SHARED RESOURCE$133,151
P30 · FY2011 · CA · contact PI
The NYSGRC: A Large Scale Center for PSI:Biology$6,125,090
U54 · FY2010 · GM · contact PI
Project 1$2,844,112
U54 · FY2010 · GM · contact PI
STRUCTURAL BIOLOGY SHARED RESOURCE$127,919
P30 · FY2010 · CA · contact PI
NYSGRC$26,345
P41 · FY2010 · RR · contact PI
STRUCTURAL BIOLOGY SHARED RESOURCE$140,528
P30 · FY2009 · CA · contact PI
SUB PROJECT 1$3,017,881
U54 · FY2008 · GM · contact PI
SUB PROJECT 1$2,982,372
U54 · FY2008 · GM · contact PI
STRUCTURAL BIOLOGY SHARED RESOURCE$132,649
P30 · FY2008 · CA · contact PI
MIXED LINEAGE LEUKEMIA (MLL) METHYLTRANSFERASE CXXC DNA BINDING DOMAIN$8,843
P41 · FY2008 · RR · contact PI
SUB PROJECT 1$2,959,242
U54 · FY2007 · GM · contact PI
consort project 1a$229,383
P01 · FY2007 · GM · contact PI
STRUCTURAL BIOLOGY SHARED RESOURCE$100,422
P30 · FY2007 · CA · contact PI
MIXED LINEAGE LEUKEMIA (MLL) METHYLTRANSFERASE CXXC DNA BINDING DOMAIN$6,983
P41 · FY2007 · RR · contact PI
SUB PROJECT 1$752,105
U54 · FY2006 · GM · contact PI
consort project 1a$225,450
P01 · FY2006 · GM · contact PI
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$1,020,000
U09 · FY2005 · RG
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$1,020,000
U09 · FY2005 · RG
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$1,020,000
U09 · FY2005 · RG
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$1,007,000
U09 · FY2005 · RG
SUB PROJECT 1$730,434
U54 · FY2005 · GM
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$250,000
U09 · FY2005 · RG
consort project 1a$225,450
P01 · FY2005 · GM
DIVISION OF MOLECULAR AND CELLULAR MECHANISMS SEPS$613,900
U09 · FY2004 · RG
consort project 1a$225,450
P01 · FY2004 · GM
STRUCTURAL BIOLOGY OF CYTOSKELETAL DYNAMICS$342,595
R01 · FY2003 · GM
consort project 1a$225,450
P01 · FY2003 · GM
STRUCTURAL BIOLOGY OF CYTOSKELETAL DYNAMICS$318,864
R01 · FY2002 · GM
STRUCTURAL BIOLOGY OF THE ALLERGIC RESPONSE$252,812
R01 · FY2002 · AI
MAD STUDIES ON ACTIN BASED CYTOSKELETON$143,176
P41 · FY2002 · RR
MAD STUDIES ON ACTIN BASED CYTOSKELETON$143,176
P41 · FY2002 · RR
STRUCTURAL BIOLOGY OF CYTOSKELETAL DYNAMICS$42,460
R01 · FY2002 · GM
STRUCTURAL BIOLOGY OF CYTOSKELETAL DYNAMICS$310,446
R01 · FY2001 · GM
STRUCTURAL BIOLOGY OF THE ALLERGIC RESPONSE$245,491
R01 · FY2001 · AI
MAD STUDIES ON ACTIN BASED CYTOSKELETON$143,176
P41 · FY2001 · RR
STRUCTURAL BIOLOGY OF CYTOSKELETAL DYNAMICS$301,650
R01 · FY2000 · GM
STRUCTURAL BIOLOGY OF ACTIN CROSSLINKING PROTEINS$251,671
R01 · FY2000 · AR
STRUCTURAL BIOLOGY OF THE ALLERGIC RESPONSE$238,381
R01 · FY2000 · AI